Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

被引:111
作者
Collino, Massimo [1 ]
Aragno, Manuela [2 ]
Castiglia, Sara [1 ]
Miglio, Gianluca [1 ]
Tomasinelli, Chiara [2 ]
Boccuzzi, Giuseppe [3 ]
Thiemermann, Christoph [4 ]
Fantozzi, Roberto [1 ]
机构
[1] Univ Turin, Dept Anat Pharmacol & Forens Med, I-10125 Turin, Italy
[2] Univ Turin, Dept Expt Med & Oncol, I-10125 Turin, Italy
[3] Univ Turin, Dept Clin Pathophysiol, I-10125 Turin, Italy
[4] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Translat Med & Therapeut, London, England
关键词
pioglitazone; high cholesterol and fructose diet; insulin resistance; inflammation; PPAR gamma; SOCS-3; ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; METABOLIC SYNDROME; GENE-EXPRESSION; KAPPA-B; RESISTANCE; ALPHA; LIVER; OBESE; SENSITIVITY;
D O I
10.1111/j.1476-5381.2010.00671.x
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Background and purpose: Nutrient overload leads to obesity and insulin resistance. Pioglitazone, a selective peroxisome proliferator-activated receptor (PPAR)gamma agonist, is currently used to manage insulin resistance, but the specific molecular mechanisms activated by PPAR gamma are not yet fully understood. Recent studies suggest the involvement of suppressor of cytokine signalling (SOCS)-3 in the pathogenesis of insulin resistance. This study aimed to investigate the hepatic signalling pathway activated by PPAR gamma activation in a non-genetic insulin-resistant animal model. Experimental approach: Male Wistar rats were maintained on a high-cholesterol fructose (HCF) diet for 15 weeks. Pioglitazone (3 mg center dot kg-1) was administered orally for the last 4 weeks of this diet. At the end of the treatment, serum was collected for biochemical analysis. Levels of PPAR gamma, SOCS-3, pro-inflammatory markers, insulin receptor substrate-2 and Akt/glycogen synthase kinase-3 beta phosphorylation were assesed in rat liver. Key results: Rats fed the HCF diet exhibited hyperlipidemia, hyperinsulinemia, impaired glucose tolerance and insulin resistance. Pioglitazone administration evoked a significant improvement in lipid metabolism and insulin responsiveness. This was accompanied by reduced hepatic expression of SOCS-3, interleukin-6, tumour necrosis factor-alpha and markers of neutrophil infiltration. Diet-induced PPAR gamma expression was unaffected by the pioglitazone treatment. Conclusion and implications: Chronic pioglitazone administration reduced hepatic inflammatory responses in rats fed a HCF diet. These effects were associated with changes in hepatic expression of SOCS-3, which may be a crucial link between the reduced local inflammation and the improved insulin signalling. This article is commented on by Chatterjee, pp. 1889-1891 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476-5381.2010.00739.x.
引用
收藏
页码:1892 / 1902
页数:11
相关论文
共 38 条
[1]
Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x
[2]
Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats [J].
Anai, M ;
Funaki, M ;
Ogihara, T ;
Terasaki, J ;
Inukai, K ;
Katagiri, H ;
Fukushima, Y ;
Yazaki, Y ;
Kikuchi, M ;
Oka, Y ;
Asano, T .
DIABETES, 1998, 47 (01) :13-23
[3]
Pioglitazone Promotes Survival and Prevents Hepatic Regeneration Failure After Partial Hepatectomy in Obese and Diabetic KK-Ay Mice [J].
Aoyama, Tomonori ;
Ikejima, Kenichi ;
Kon, Kazuyoshi ;
Okumura, Kyoko ;
Arai, Kumiko ;
Watanabe, Sumio .
HEPATOLOGY, 2009, 49 (05) :1636-1644
[4]
SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats [J].
Aragno, Manuela ;
Tomasinelli, Chiara E. ;
Vercellinatto, Ilenia ;
Catalano, Maria G. ;
Collino, Massimo ;
Fantozzi, Roberto ;
Danni, Oliviero ;
Boccuzzi, Giuseppe .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (07) :1067-1074
[5]
High dietary fat promotes Syndrome X in nonobese rats [J].
Axen, KV ;
Dikeakos, A ;
Sclafani, A .
JOURNAL OF NUTRITION, 2003, 133 (07) :2244-2249
[6]
The role of carbohydrates in insulin resistance [J].
Bessesen, DH .
JOURNAL OF NUTRITION, 2001, 131 (10) :2782S-2786S
[7]
Tumor necrosis factor-α induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase [J].
Cheung, AT ;
Wang, JF ;
Ree, D ;
Kolls, JK ;
Bryer-Ash, M .
DIABETES, 2000, 49 (05) :810-819
[8]
GSK3 inhibitors: Development and therapeutic potential [J].
Cohen, P ;
Goedert, M .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (06) :479-487
[9]
Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma [J].
DeVos, P ;
Lefebvre, AM ;
Miller, SG ;
GuerreMillo, M ;
Wong, K ;
Saladin, R ;
Hamann, LG ;
Staels, B ;
Briggs, MR ;
Auwerx, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1004-1009